DrugPatentWatch Database Preview
GAZYVA Drug Profile
» See Plans and Pricing
Summary for Tradename: GAZYVA
| Patents: | 37 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
| Recent Clinical Trials: | See clinical trials for GAZYVA |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for GAZYVA |
Recent Clinical Trials for GAZYVA
Identify potential brand extensions & biosimilar entrants
| Sponsor | Phase |
|---|---|
| Celgene | Phase 1 |
| Joseph Tuscano | Phase 1 |
| Massachusetts General Hospital | Phase 2 |
Recent Litigation for GAZYVA
Identify key patents and potential future biosimilar entrants
District Court Litigation
| Case Name | Date |
|---|---|
| ABBVIE INC. v. DR. REDDY'S LABORATORIES, INC. | 2020-07-22 |
Pharmacology for GAZYVA
| Mechanism of Action | CD20-directed Antibody Interactions |
Patent Text Search: US Patents for GAZYVA
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genentech | GAZYVA | obinutuzumab | INJECTABLE;INJECTION | 125486 | 001 | 2013-11-01 | Start Trial | The United States of America, as represented by the Secretary, Department of Health and Human Services (Washington, DC) University of Virginia Patent Foundation (Charlottesville, VA) | 2034-01-08 | RX | Orphan | search |
| Genentech | GAZYVA | obinutuzumab | INJECTABLE;INJECTION | 125486 | 001 | 2013-11-01 | Start Trial | PRINCIPIA BIOPHARMA INC. (South San Francisco, CA) | 2034-02-21 | RX | Orphan | search |
| Genentech | GAZYVA | obinutuzumab | INJECTABLE;INJECTION | 125486 | 001 | 2013-11-01 | Start Trial | Celgene Corporation (Summit, NJ) | 2035-12-02 | RX | Orphan | search |
| Genentech | GAZYVA | obinutuzumab | INJECTABLE;INJECTION | 125486 | 001 | 2013-11-01 | Start Trial | Cipla Limited (Mumbai, IN) | 2036-06-30 | RX | Orphan | search |
| Genentech | GAZYVA | obinutuzumab | INJECTABLE;INJECTION | 125486 | 001 | 2013-11-01 | Start Trial | BEYONDBIO INC. (Daejeon, KR) | 2035-02-04 | RX | Orphan | search |
| Genentech | GAZYVA | obinutuzumab | INJECTABLE;INJECTION | 125486 | 001 | 2013-11-01 | Start Trial | UNIVERSITY OF UTAH RESEARCH FOUNDATION (Salt Lake City, GA) | 2033-03-12 | RX | Orphan | search |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for GAZYVA
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Canada | 2929918 | Start Trial |
| China | 111437386 | Start Trial |
| Australia | 2002359338 | Start Trial |
| Israel | 257839 | Start Trial |
| Canada | 2787054 | Start Trial |
| Hong Kong | 1117761 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
